Opinion

Video

Factors Informing Individualized Treatment Decision-Making for HER2-Positive Metastatic Breast Cancer

Author(s):

Sara M. Tolaney, MD, MPH

Sara M. Tolaney, MD, MPH explains that treatment decisions for metastatic breast cancer are based on the current biopsy showing receptor status, but prior biopsies over the full course of disease are considered as well, particularly for HER2 targeted therapies which may work even if HER2 low expression occurred years earlier.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of a woman wearing a headband and glasses
Image of doctor.
Image of woman.
Image of Doctor.
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Image od grey haired Doctor.
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Image of man with grey hair.
Related Content
The first patient has been dosed in a phase 1/2 trial investigating treatment with AP402, a T-cell engager, for patients with HER2-positive cancers: stock.adobe.com.
April 23rd 2025

First Patient Dosed with AP402 in a Trial for HER2 Advanced Tumors

Spencer Feldman
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Trodelvy plus Keytruda was associated with an improvement in disease progression in mTNBC: © stock.adobe.com.
April 21st 2025

Trodelvy Plus Keytruda May Slow Progression in mTNBC

Alex Biese
In some patients with advanced triple-negative breast cancer, Trodelvy plus Keytruda was associated with an improvement in disease progression.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Illustration of Debbie.
April 17th 2025

How I Manage When My Social Media Friends with Cancer Disappear

Debbie Legault
I stay in the cancer social media world because it helps me cope, even when friends disappear and I’m left wondering if they’re resting, retreating or gone.
Illustration of women.
April 16th 2025

Sometimes, Distractions Help During Breast Cancer

Laura Yeager
After a mammogram and breast cancer scare, a Broadway show provided a welcome distraction and joy, reminding me of life's beauty.